Inhibition of β-adrenergic binding by fungal metabolites

References

1. Chang RSL, Lotti VJ, Monaghan RL. et al. A potent nonpeptide eholecystokmin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 1985; 230:177–179
   [Google Scholar]
2. Schar G, Stover EP, Clemons KV, Feldman D, Stevens DA. Progesterone binding and inhibition of growth in Trichophyton mentagrophytes. Infect Immun 1986; 52:763–767
   [Google Scholar]
3. Stover EP, Schar G, Clemons KV, Stevens DA, Feldman D. Estradiol-binding proteins from mycelial and yeast-form cultures of Paracoccidioides brasiliensis. Infect Immun 1986; 51:199–203
   [Google Scholar]
4. Feldman D, Stathis PA, Hirst MA, Stover EP, Do YS. Saccharomyces cererisiae produces a yeast substance that exhibits estrogenic activity in mammalian systems. Science 1984; 224:1109–1111
   [Google Scholar]
5. Brown SD, Montie TC. Beta-adrenergic blocking activity of Yersiniapcstis murine toxin. Infect Immun 1977; 18:85–93
   [Google Scholar]
6. Dhainaut JF, Huet Y, Kahan A. et al. Acute myocardial failure during Yersinia enterocolitica infection. Intensite Care Med 1982; 8:51–53
   [Google Scholar]
7. Schreurs AJM, Vcrhoef J, Nijkamp FP. Bacterial cell wall components decrease the number of guinea-pig lung beta-adrenoceptors. Eur J Pharmacol 1983; 876:127–132
   [Google Scholar]
8. Doma ST. Inhibition of beta-adrenergic ligand-receptor in teraction by bacteria. Am Fed Clin Res 1985; 3:400A
   [Google Scholar]
9. Donta ST. A bacterial inhibitor of mammalian neuro transmitter binding and function. Abstracts of the Annual Meeting of the American Society for Microbiology 1986K-181
   [Google Scholar]
10. Coleman WH, Donta ST. Inhibition of beta-adrenergic receptor binding to mammalian cells by fungal culture filtrates. Abstracts of the Annual Meeting of the American Society for Microbiology 1988F-30
    [Google Scholar]
11. Donta ST, Shanley JD. Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor. J Virol 1990; 64:639–641
    [Google Scholar]
12. Umezawa H. (ed) Enzyme inhibitors of microbial origin. Baltimore: University Park Press; 197211
    [Google Scholar]
13. Chakrabarti DK, BasuChaudhury KC, Ghosal S. Toxic substances produced by Fusarium. 111. Production and screening of phytotoxic substances of F. oxysporum f. sp. carthami responsible for the wilt disease of safifiow’er Carthamus tinctorius Linn. Experientia 1976; 32:608–609
    [Google Scholar]
14. Harborne JB. Introduction to ecological biochemistry. New York: Academic Press; 1985328
    [Google Scholar]
15. Povey N, Holm RA. Band spreading in molecular-sieve chromatography. J Chromatogr 1970; 46:33–47
    [Google Scholar]
16. Anaissie E, Kantarjian H, Jones P. et al. Fusarium: a newly recognized pathogen in immunosuppressed patients. Cancer 1986; 57:2141–2145
    [Google Scholar]
17. Anaissie E, Kantarjian H, Ro J. et al. The emerging role of Fusarium infections in patients with cancer. Medicine 1988; 67:77–83
    [Google Scholar]